AntibioticDB

Amifloxacin (WIN 49375; WIN 49375-3)

Fluoroquinolone

Sanofi Winthrop (Sanofi Aventis, France); Yamanouchi Pharma. (Astellas Pharma., Japan)

N/A

Highest development stage: Phase 2
Development dropped
Gram-positive activity
Reason dropped: A number of frequent side effects: dizziness, gastrointestinal disorders, skin disorders and headaches
GtoPDB link: https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10758
Source: https://journals.asm.org/doi/epdf/10.1128/aac.26.2.275
Compound/Drug Structure: https://pubchem.ncbi.nlm.nih.gov/compound/55492